Table 1.

Patient characteristics of stage IV lung, oesophageal, pancreatic and stomach cancers diagnosed in 2013–2014 in England

	Number of cancers diagnosed										Total
	NSCLC	%	SCLC	%	Oesophagus	%	Stomach	%	Pancreas	%
Total	30,431		5,079		4,023		3,588		7,111		50,232
Year of diagnosis
2013	14,979	49	2,532	50	1,847	46	1,783	50	3,288	46	24,429
2014	15,452	51	2,547	50	2,176	54	1,805	50	3,823	54	25,803
Sex
Male	16,839	55	2,712	53	2,898	72	2,401	67	3,715	52	28,565
Female	13,592	45	2,367	47	1,125	28	1,187	33	3,396	48	21,667
Age at cancer diagnosis
<50	847	3	148	3	175	4	262	7	315	4	1,747
50–59	2,953	10	697	14	557	14	366	10	829	12	5,402
60–69	8,135	27	1,761	35	1,218	30	770	21	1,881	26	13,765
70–79	10,075	33	1,771	35	1,234	31	1,180	33	2,275	32	16,535
80+	8,421	28	702	14	839	21	1,010	28	1,811	25	12,783
Charlson comorbidity index
0	22,840	75	3,922	77	3,285	82	2,816	78	5,461	77	38,324
1	3,661	12	578	11	373	9	395	11	845	12	5,852
2	2,007	7	331	7	192	5	228	6	435	6	3,193
3+	1,923	6	248	5	173	4	149	4	370	5	2,863
Deprivation quintile
1: least deprived	4,377	14	623	12	731	18	601	17	1,445	20	7,777
2	5,516	18	887	17	832	21	733	20	1,531	22	9,499
3	6,411	21	1,009	20	857	21	741	21	1,577	22	10,595
4	6,862	23	1,192	23	832	21	769	21	1,349	19	11,004
5: most deprived	7,265	24	1,368	27	771	19	744	21	1,209	17	11,357
Ethnicity
White	28,133	92	4,817	95	3,781	94	3,198	89	6,411	90	46,340
Non-white	1,182	4	120	2	91	2	264	7	376	5	2,033
Unknown	1,116	4	142	3	151	4	126	4	324	5	1,859
Performance status
0	2,567	8	414	8	586	15	369	10	418	6	4,354
1+	14,985	49	3,109	61	1,342	33	1,164	32	1,161	16	21,761
Unknown	12,879	42	1,556	31	2,095	52	2,055	57	5,532	78	24,117

NSCLC non-small cell lung cancer, SCLC small cell lung cancer